EHMT2 and cancer: In this review, we discuss the physiological role of GLP and G9a, their oncogenic functions on hematological malignancies from lymphoid lineage, the therapeutic potential of epigenetic drugs in cancer, and the scientific challenges that need to be overcome for epigenetic drugs to become a therapeutic option for cancer.